Biological barriers—such as the intestinal epithelium, the blood-brain barrier, and the vascular endothelium—are dynamic, highly regulated cellular sheets that control the passage of ions, molecules, and cells. At the heart of this regulation are intercellular junctions (like tight junctions and adherens junctions) that seal the paracellular space between adjacent cells. When these junctions are compromised by disease, toxins, or pathogens, the barrier becomes "leaky," leading to systemic inflammation or tissue damage.
To understand and treat these conditions, researchers must accurately quantify barrier integrity. Rather than relying solely on static visual snapshots from microscopy, modern methodologies leverage biophysical principles to measure barrier function dynamically, both in vitro and in vivo.
Electrical Resistance as a Proxy for Junctional Sealing
How do we measure the tightness of a cellular sheet in real time without destroying it? The answer lies in Ohm's Law ($V = IR$). By passing a weak alternating electrical current across a cell monolayer, we can measure its electrical impedance. This technique is known as Transepithelial or Transendothelial Electrical Resistance (TEER).
To understand why TEER works, consider the path an electrical current must take. In an open solution, ions (such as $\text{Na}^+$ and $\text{Cl}^-$) move freely, resulting in low electrical resistance. When a monolayer of endothelial or epithelial cells is introduced, the ions are forced to travel either through the cells (the transcellular path) or between them (the paracellular path). Because cell membranes are highly resistive lipid bilayers, the electrical current primarily flows through the narrow paracellular spaces. Therefore, the total electrical resistance of the monolayer is directly determined by the tightness of the intercellular junctions.
A high TEER value indicates a well-formed, highly impermeable barrier, while a drop in TEER signals junctional disruption. For instance, Olga Danov et al. used TEER to demonstrate how cigarette smoke physically degrades the integrity of lung epithelial barriers, making them more vulnerable to viral infections (Cigarette Smoke Affects Dendritic Cell Populations, Epithelial Barrier Function, and the Immune Response to Viral Infection With H1N1). Similarly, Mingxing Tang et al. tracked the real-time breakdown of airway organoid barriers during bacterial infection by monitoring drops in electrical resistance (Evaluating Bacterial Pathogenesis Using a Model of Human Airway Organoids Infected with Pseudomonas aeruginosa Biofilms).
The primary advantage of TEER is its non-destructive, continuous nature. Wei Zhang et al. and Shang Li et al. highlighted how real-time impedance fluctuations allow for the immediate detection of endothelial barrier changes in response to pharmacological agents (Catalpol downregulates vascular endothelial-cadherin expression and induces vascular hyperpermeability; Discovery of a ROCK inhibitor, FPND, which prevents cerebral hemorrhage through maintaining vascular integrity by interference with VE-cadherin).
This biophysical metric has become a standard in complex in vitro co-cultures, such as blood-brain barrier models mapping tumor metastasis or encephalopathy (Chenlong Li et al., miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8; Yuhan Liu et al., circRNA-PTPN4 mediated regulation of FOXO3 and ZO-1 expression: implications for blood–brain barrier integrity and cognitive function in uremic encephalopathy). Furthermore, the concept has been extended computationally; Benjamin Raach et al. demonstrated that TEER can be simulated from membrane connectivity and image data to bridge virtual tissue models with experimental measurements (Influence of cell type specific infectivity and tissue composition on SARS-CoV-2 infection dynamics within human airway epithelium).
Macromolecular Tracer Flux and Size-Selectivity
While TEER is exceptionally sensitive to the movement of tiny ions, it does not tell the whole story. A barrier might restrict ions but still allow larger, harmful macromolecules to pass if the structural failure is localized or heterogeneous. To capture this, researchers pair electrical measurements with paracellular permeability assays using fluorescently labeled tracers.
In a tracer flux assay, a known concentration of an inert, labeled macromolecule—such as fluorescein isothiocyanate (FITC)-conjugated dextran or albumin—is introduced to the apical (top) side of a cellular barrier. Over time, the amount of tracer that diffuses to the basolateral (bottom) side is measured. Because these molecules are too large to pass through intact cell membranes, their translocation depends entirely on the physical dimensions of the paracellular gaps.
By varying the molecular weight of the tracers, researchers can probe the size-selectivity of the barrier. A single-author study by Sohee Lee utilized a multi-scale tracer extravasation assay with in vivo two-photon imaging to distinguish between minor tight junction degradation and major structural barrier failure in the brain (Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood-brain barrier permeability in chronically stressed mice).
This dual approach—combining TEER for ion restriction and tracer flux for macromolecular exclusion—provides a comprehensive functional map of barrier integrity. For instance, Hengli Guo et al., Honglian Wang et al., and Jiamin Tu et al. routinely deployed both techniques to validate how therapeutic compounds protect gut and vascular linings from inflammatory breakdown (Kuwanon G Preserves LPS-Induced Disruption of Gut Epithelial Barrier In Vitro; Ginsenoside Rg1 attenuates high glucose‑induced endothelial barrier dysfunction in human umbilical vein endothelial cells by protecting the endothelial glycocalyx; Da-Cheng-Qi decoction improves severe acute pancreatitis capillary leakage syndrome by regulating tight junction-associated proteins).
Translating Barrier Quantification In Vivo and Clinically
In a living organism, inserting electrodes on both sides of an epithelial layer is often impossible. To quantify barrier integrity in vivo, researchers rely on circulating biomarkers and advanced pharmacokinetic imaging.
Biomarker-Based Proxies
When an epithelial barrier like the gut lining breaks down, intracellular enzymes unique to the mucosa leak into the systemic circulation. Sujuan Ding et al. and Chuangang Li et al. demonstrated that serum concentrations of diamine oxidase (DAO) and D-lactate serve as reliable quantitative proxies for intestinal barrier structural failure (Effects of Lactobacillus plantarum 15-1 and fructooligosaccharides on the response of broilers to pathogenic Escherichia coli O78 challenge; Lactoferrin and Osteopontin Cooperatively Promote Intestinal Epithelial Maturation in Neonatal Mice by Activating the Brg1/Notch1/Hes1 Pathway).
Similarly, Jianhua Zheng et al. paired serum intestinal fatty acid-binding protein (I-FABP) levels with oral FITC-dextran clearance to track hypoxic gut injury (Tryptophan attenuates acute hypoxic stress-induced intestinal injury through the modulation of intestinal barrier integrity and gut microbiota homeostasis). For the blood-cerebrospinal fluid barrier, Alexander Wuschek et al. highlighted the use of the albumin CSF-to-serum ratio, which standardizes barrier permeability against systemic protein fluctuations (CSF Protein Concentration Shows No Correlation With Brain Volume Measures).
Pharmacokinetic Imaging
In clinical settings, barrier leakiness can be mapped non-invasively using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI). Guanzhong Gong et al. explained how tracking the extravasation of an injected contrast agent from the blood into tissue over time allows clinicians to calculate $K^{trans}$, a volume transfer constant that mathematically defines the permeability and leakiness of the local microenvironment (The therapeutic utility of combining dynamic contrast-enhanced magnetic resonance imaging with arterial spin labeling in the staging of nasopharyngeal carcinoma).
By combining electrical, macromolecular, and biochemical metrics, researchers can build a multi-scale understanding of how biological barriers function in health and fail in disease.
Key Foundational Work
Application-Specific Interconnection Network Design in Clustered DSP Processors (2003) — contributed 1 concept elements to this direction.
Correlation of transarterial transport of various dextrans with their physicochemical properties (2000) — contributed 1 concept elements to this direction.